{"transactions":[{"id":1717438,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":96291,"kind":"person","name":"Paley Jeffrey","position":1,"cik":"0001595327","reported_name":"Paley Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-12-08T17:01:18.000Z","date":"2023-11-08","kind":"sale","planned":false,"acquired":false,"shares":255,"price":3.76,"value":958.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person realized short-swing profits under Section 16(b) of the Securities Exchange Act of 1934, as amended, as a result of sales of the Issuer's common stock reported herein, as well as the sales reported on a Form 4 filed November 29, 2023, being matched against non-exempt purchases of 4,245 shares of common stock made on September 21, 2023. Accordingly, the reporting person has paid to the Issuer (i) $1,724.98 in connection with the matched sales reported herein and (ii) $4,189.95 in connection with the matched sales made on November 28, 2023, representing the aggregate short-swing profit realized by the reporting person, less transaction costs. Includes 10,000 restricted units of which will vest in full on July 1, 2024 and 27,472 restricted stock units of which will vest on July 21, 2024."}],"balance_after":114217,"source":{"system":"sec-edgar","filing":"0001104659-23-124743","document":"tm2332498-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595327/000110465923124743/tm2332498-1_4seq1.xml","form_type":"4"}},{"id":1717437,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":96291,"kind":"person","name":"Paley Jeffrey","position":1,"cik":"0001595327","reported_name":"Paley Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-12-08T17:01:18.000Z","date":"2023-11-07","kind":"sale","planned":false,"acquired":false,"shares":2245,"price":3.48,"value":7812.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person realized short-swing profits under Section 16(b) of the Securities Exchange Act of 1934, as amended, as a result of sales of the Issuer's common stock reported herein, as well as the sales reported on a Form 4 filed November 29, 2023, being matched against non-exempt purchases of 4,245 shares of common stock made on September 21, 2023. Accordingly, the reporting person has paid to the Issuer (i) $1,724.98 in connection with the matched sales reported herein and (ii) $4,189.95 in connection with the matched sales made on November 28, 2023, representing the aggregate short-swing profit realized by the reporting person, less transaction costs. Includes 10,000 restricted units of which will vest in full on July 1, 2024 and 27,472 restricted stock units of which will vest on July 21, 2024."}],"balance_after":114472,"source":{"system":"sec-edgar","filing":"0001104659-23-124743","document":"tm2332498-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595327/000110465923124743/tm2332498-1_4seq1.xml","form_type":"4"}},{"id":1727435,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":96291,"kind":"person","name":"Paley Jeffrey","position":1,"cik":"0001595327","reported_name":"Paley Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-11-29T16:42:16.000Z","date":"2023-11-28","kind":"sale","planned":false,"acquired":false,"shares":1745,"price":5.22,"value":9108.9,"ownership":{"direct":true},"balance_after":70727,"source":{"system":"sec-edgar","filing":"0001104659-23-122072","document":"tm2331786-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595327/000110465923122072/tm2331786-1_4seq1.xml","form_type":"4"}},{"id":1762372,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":96291,"kind":"person","name":"Paley Jeffrey","position":1,"cik":"0001595327","reported_name":"Paley Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-10-10T16:41:00.000Z","date":"2023-10-06","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":2.98,"value":44700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on October 6, 2023, was $2.97 to $2.99. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":72472,"source":{"system":"sec-edgar","filing":"0001104659-23-108323","document":"tm2328171-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595327/000110465923108323/tm2328171-1_4seq1.xml","form_type":"4"}},{"id":1773770,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":96291,"kind":"person","name":"Paley Jeffrey","position":1,"cik":"0001595327","reported_name":"Paley Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-09-25T16:01:37.000Z","date":"2023-09-21","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":2.97,"value":89100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on September 21, 2023, was $2.82 to $3.00. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":57472,"source":{"system":"sec-edgar","filing":"0001104659-23-103509","document":"tm2326865-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595327/000110465923103509/tm2326865-1_4seq1.xml","form_type":"4"}},{"id":1823402,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":96291,"kind":"person","name":"Paley Jeffrey","position":1,"cik":"0001595327","reported_name":"Paley Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-07-25T16:06:50.000Z","date":"2023-07-21","kind":"grant","planned":false,"acquired":true,"shares":27472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 21, 2023, the reporting person was granted 27,472 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 21, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 61,717 restricted stock units, 27,472 units of which will vest in full on July 21, 2024 as set forth in footnote 1, and 10,000 units of which will vest on July 1, 2024."}],"balance_after":71717,"source":{"system":"sec-edgar","filing":"0001104659-23-083834","document":"tm2321950-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595327/000110465923083834/tm2321950-2_4seq1.xml","form_type":"4"}},{"id":2202574,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":96291,"kind":"person","name":"Paley Jeffrey","position":1,"cik":"0001595327","reported_name":"Paley Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-07-25T09:38:30.000Z","date":"2022-07-21","kind":"grant","acquired":true,"shares":14245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 21, 2022, the reporting person was granted 14,245 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 21, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 34,245 restricted stock units, 14,245 of which will vest as set forth in footnote 1, and 20,000 of which will vest in increments as follows: (1) 10,000 units on July 1, 2023, and (2) 10,000 units on July 1, 2024."}],"balance_after":44245,"source":{"system":"sec-edgar","filing":"0001104659-22-082289","document":"tm2221508-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595327/000110465922082289/tm2221508-5_4seq1.xml","form_type":"4"}},{"id":2307180,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":96291,"kind":"person","name":"Paley Jeffrey","position":1,"cik":"0001595327","reported_name":"Paley Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2022-04-04T16:49:21.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 30,000 restricted stock units relating to this grant will vest in three increments as follows: (1) 10,000 units on July 1, 2022, (2) 10,000 units on July 1, 2023, and (3) 10,000 units on July 1, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods as set forth in footnote 1."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001104659-22-042280","document":"tm2211324-10_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595327/000110465922042280/tm2211324-10_4.xml","form_type":"4"}},{"id":3733644,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":96291,"kind":"person","name":"Paley Jeffrey","position":1,"cik":"0001595327","reported_name":"Paley Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-12T13:15:38.000Z","date":"2018-12-10","kind":"purchase","acquired":true,"shares":5000,"price":4.76,"value":23800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,663 shares of restricted stock."}],"balance_after":79663,"source":{"system":"sec-edgar","filing":"0001144204-18-064217","document":"tv508813_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595327/000114420418064217/tv508813_form4.xml","form_type":"4"}},{"id":3733643,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":96291,"kind":"person","name":"Paley Jeffrey","position":1,"cik":"0001595327","reported_name":"Paley Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-12T13:15:38.000Z","date":"2018-12-03","kind":"purchase","acquired":true,"shares":10000,"price":5.4754,"value":54754.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on December 3, 2018 was $5.4734 to $5.4774. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,663 shares of restricted stock."}],"balance_after":74663,"source":{"system":"sec-edgar","filing":"0001144204-18-064217","document":"tv508813_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595327/000114420418064217/tv508813_form4.xml","form_type":"4"}},{"id":3849359,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":96291,"kind":"person","name":"Paley Jeffrey","position":1,"cik":"0001595327","reported_name":"Paley Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-08T21:39:05.000Z","date":"2018-08-07","kind":"gift","acquired":true,"shares":14663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 14,663 shares of restricted common stock will vest on August 7, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,663 shares of restricted stock."}],"balance_after":64663,"source":{"system":"sec-edgar","filing":"0001144204-18-042950","document":"tv500464_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595327/000114420418042950/tv500464_form4.xml","form_type":"4"}},{"id":4478989,"issuer":{"id":151953,"kind":"organization","name":"IMMUNE PHARMACEUTICALS INC","symbol":"IMNPQ"},"owners":[{"id":96291,"kind":"person","name":"Paley Jeffrey","position":1,"cik":"0001595327","reported_name":"Paley Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-01-27T19:15:48.000Z","date":"2017-01-25","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options shall vest in equal quarterly installments over a one-year period from the date of grant."}],"balance_after":700000,"derivative":{"exercise_price":0.2,"exercise_date":"2017-01-25","expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001144204-17-004430","document":"v457813_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1208261/000114420417004430/v457813_form4.xml","form_type":"4"}}]}